CGON

CG ONCOLOGY INC

CGON·156944100·US·Common Stock·Healthcare - Biotechnology-Activist

CGON (CG ONCOLOGY INC) is held by 129 institutional investors as of Q2 2026. Largest holders: RTW INVESTMENTS, LP ($605M), BlackRock, Inc. ($444.5M), WELLINGTON MANAGEMENT GROUP LLP ($378.3M). Net institutional sentiment: Mixed.

129
Holders
(8 Elite)
$4B
Total Value
61% (135)
Consensus
82 buying - 53 selling
13F: Insider & Congress: Updated regularly
CGON

Smart Money Verdict

View all
Loading verdict
Held by 129 funds
8 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Aug 18, 2026 · Activists Aug 14, 2026 · Congress none

InsiderPEPOST LEONARD ESell $75KAug 14, 2026
InsiderPEPOST LEONARD EExercise 1K shAug 14, 2026
ActivistRTW Investments, LPRTW Investments, LP9.7%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
8.5M(+21.9%)$605M5.2%+39.11%
74
Increased
6.3M(+23.5%)$444.5M0.0%+104.76%
38
Decreased
5.3M(-0.9%)$378.3M0.1%+114.02%
0
Increased
4.2M(+10.5%)$295.7M0.0%+138.46%
34
Increased
3.5M(+12.0%)$246.2M0.0%+27.16%
34
Increased
3.4M(+29.9%)$244.2M0.0%+76.60%
39
Increased
3.3M(+9.3%)$235.7M0.0%+27.62%
34
Increased
2.2M(+34.8%)$153M0.0%+65.31%
39
Decreased
1.3M(-12.9%)$93.3M0.0%+104.92%
0
Increased
1.4M(+6.5%)$93M0.0%+109.02%
32
Increased
1.2M(+126.3%)$83.6M0.0%+50.92%
48
Decreased
984,918(-32.0%)$70M0.0%+113.96%
0
Decreased
977,695(-25.5%)$69.5M0.0%+184.88%
0
Decreased
857,713(-26.0%)$60.9M0.0%+169.41%
0
Decreased
761,807(-28.5%)$54.1M0.0%+158.46%
0
Increased
735,736(+0.8%)$52.3M0.0%+95.13%
29
Increased
726,154(+147x)$51.6M0.0%+10.78%
47
Increased
677,912(+30.4%)$48.2M0.0%+66.27%
37
Increased
627,185(+15.6%)$44.6M0.0%+82.48%
34
Increased
538,289(+14.5%)$38.2M0.0%+26.74%
33

Showing 1-20 of 141

1 / 8
CGONCGONCG ONCOLOGY INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used